Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Bloom

Showing results (101-110 of 252) with videos related to

Pageof 26
Sort By:
Obesity (Silver Spring, Md.)|February 14, 2009
Peripheral and central administration of xenin and neurotensin suppress food intake in rodentsJennifer H Cooke, Michael Patterson, Sejal R Patel, et al.
Biochemical and Biophysical Research Communications|September 8, 2004
Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weightEmily L Thompson, Kevin G Murphy, Jeannie F Todd, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapyWaljit S Dhillo, Channa N L Jayasena, James E Jackson, et al.
Molecular Interventions|April 12, 2008
The obesity epidemic: pharmacological challengesStephen R Bloom, Francis P Kuhajda, Ismail Laher, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2005
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngiomaAnthony P Goldstone, Michael Patterson, Nila Kalingag, et al.
Plos One|May 22, 2014
Quantification of rat kisspeptin using a novel radioimmunoassayJames S Kinsey-Jones, Kylie E Beale, Joy Cuenco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2017
The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese VolunteersTricia Tan, Preeshila Behary, George Tharakan, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2005
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trialKatie Wynne, Kalli Giannitsopoulou, Caroline J Small, et al.
The American Journal of Clinical Nutrition|February 28, 2002
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndromeAnthony P Goldstone, Audrey E Brynes, E Louise Thomas, et al.
Plos One|August 27, 2013
Substance P immunoreactivity exhibits frequent colocalization with kisspeptin and neurokinin B in the human infundibular regionErik Hrabovszky, Beáta Á Borsay, Kálmán Rácz, et al.
Pageof 26

Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Obesity (Silver Spring, Md.)|February 14, 2009
Peripheral and central administration of xenin and neurotensin suppress food intake in rodentsJennifer H Cooke, Michael Patterson, Sejal R Patel, et al.
Biochemical and Biophysical Research Communications|September 8, 2004
Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weightEmily L Thompson, Kevin G Murphy, Jeannie F Todd, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapyWaljit S Dhillo, Channa N L Jayasena, James E Jackson, et al.
Molecular Interventions|April 12, 2008
The obesity epidemic: pharmacological challengesStephen R Bloom, Francis P Kuhajda, Ismail Laher, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2005
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngiomaAnthony P Goldstone, Michael Patterson, Nila Kalingag, et al.
Plos One|May 22, 2014
Quantification of rat kisspeptin using a novel radioimmunoassayJames S Kinsey-Jones, Kylie E Beale, Joy Cuenco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2017
The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese VolunteersTricia Tan, Preeshila Behary, George Tharakan, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2005
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trialKatie Wynne, Kalli Giannitsopoulou, Caroline J Small, et al.
The American Journal of Clinical Nutrition|February 28, 2002
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndromeAnthony P Goldstone, Audrey E Brynes, E Louise Thomas, et al.
Plos One|August 27, 2013
Substance P immunoreactivity exhibits frequent colocalization with kisspeptin and neurokinin B in the human infundibular regionErik Hrabovszky, Beáta Á Borsay, Kálmán Rácz, et al.
Pageof 26